Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Participant Centered Active Surveillance for Adverse Event Following Measles Immunization in Gedeo Zone, Ethiopia, 2022. A Multi-center Open-label Randomized Control Trial

NCT05803538 is registered in ClinicalTrials.gov with Dilla University as lead sponsor.

NCT NCT05803538
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05803538 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Participant Centered Active Surveillance for Adverse Event Following Measles Immunization in Gedeo Zone, Ethiopia, 2022. A Multi-center Open-label Randomized Control Trial
Lead sponsor
Dilla University
Phase
Not applicable
Overall status
Unknown status
Start date
May 15, 2023
Completion date
January 30, 2024
Enrollment
391 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

measles